These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 16414974

  • 1. Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.
    Krause S, Kuckelkorn U, Dörner T, Burmester GR, Feist E, Kloetzel PM.
    Ann Rheum Dis; 2006 Aug; 65(8):1021-7. PubMed ID: 16414974
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i).
    Scheffler S, Kuckelkorn U, Egerer K, Dörner T, Reiter K, Soza A, Burmester GR, Feist E.
    Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405
    [Abstract] [Full Text] [Related]

  • 3. Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndrome.
    Egerer T, Martinez-Gamboa L, Dankof A, Stuhlmüller B, Dörner T, Krenn V, Egerer K, Rudolph PE, Burmester GR, Feist E.
    Arthritis Rheum; 2006 May; 54(5):1501-8. PubMed ID: 16646031
    [Abstract] [Full Text] [Related]

  • 4. Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndrome.
    Martinez-Gamboa L, Lesemann K, Kuckelkorn U, Scheffler S, Ghannam K, Hahne M, Gaber-Elsner T, Egerer K, Naumann L, Buttgereit F, Dörner T, Kloetzel PM, Burmester GR, Faustman DL, Feist E.
    J Rheumatol; 2013 May; 40(5):663-73. PubMed ID: 23504381
    [Abstract] [Full Text] [Related]

  • 5. Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome.
    Morawietz L, Martinez-Gamboa L, Scheffler S, Hausdorf G, Dankof A, Kuckelkorn U, Doerner T, Egerer K, Burmester GR, Faustman DL, Feist E.
    J Rheumatol; 2009 Dec; 36(12):2694-703. PubMed ID: 19833746
    [Abstract] [Full Text] [Related]

  • 6. Expression of proteasome immunosubunit in labial glands of patients with primary Sjogren's syndrome.
    Zhen L, Yu-feng L, Jin-ling C, Chun-lan G, Hong-lin W, Jing-lian X, Jie Z, Ding Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):146-50. PubMed ID: 21529441
    [Abstract] [Full Text] [Related]

  • 7. Sequence information within proteasomal prosequences mediates efficient integration of beta-subunits into the 20 S proteasome complex.
    Schmidt M, Zantopf D, Kraft R, Kostka S, Preissner R, Kloetzel PM.
    J Mol Biol; 1999 Apr 23; 288(1):117-28. PubMed ID: 10329130
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type.
    Feist E, Kuckelkorn U, Dörner T, Dönitz H, Scheffler S, Hiepe F, Kloetzel PM, Burmester GR.
    Arthritis Rheum; 1999 Apr 23; 42(4):697-702. PubMed ID: 10211883
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune response to proteasome activator 28alpha in patients with connective tissue diseases.
    Matsushita M, Takasaki Y, Takeuchi K, Yamada H, Matsudaira R, Hashimoto H.
    J Rheumatol; 2004 Feb 23; 31(2):252-9. PubMed ID: 14760793
    [Abstract] [Full Text] [Related]

  • 10. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.
    Ann Rheum Dis; 2007 Jun 23; 66(6):790-7. PubMed ID: 17185325
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
    Busse A, Kraus M, Na IK, Rietz A, Scheibenbogen C, Driessen C, Blau IW, Thiel E, Keilholz U.
    Cancer; 2008 Feb 01; 112(3):659-70. PubMed ID: 18181098
    [Abstract] [Full Text] [Related]

  • 12. Immunoproteasome-specific inhibitors and their application.
    Basler M, Groettrup M.
    Methods Mol Biol; 2012 Feb 01; 832():391-401. PubMed ID: 22350900
    [Abstract] [Full Text] [Related]

  • 13. Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines.
    Niewerth D, Kaspers GJ, Assaraf YG, van Meerloo J, Kirk CJ, Anderl J, Blank JL, van de Ven PM, Zweegman S, Jansen G, Cloos J.
    J Hematol Oncol; 2014 Jan 13; 7():7. PubMed ID: 24418325
    [Abstract] [Full Text] [Related]

  • 14. The immunoproteasome in antigen processing and other immunological functions.
    Basler M, Kirk CJ, Groettrup M.
    Curr Opin Immunol; 2013 Feb 13; 25(1):74-80. PubMed ID: 23219269
    [Abstract] [Full Text] [Related]

  • 15. Pathological keratinisation in the conjunctival epithelium of Sjögren's syndrome.
    Hirai N, Kawasaki S, Tanioka H, Connon CJ, Yamasaki K, Yokoi N, Komuro A, Kinoshita S.
    Exp Eye Res; 2006 Mar 13; 82(3):371-8. PubMed ID: 16143330
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S.
    Arthritis Rheum; 2002 Oct 13; 46(10):2730-41. PubMed ID: 12384933
    [Abstract] [Full Text] [Related]

  • 17. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.
    Basler M, Lauer C, Moebius J, Weber R, Przybylski M, Kisselev AF, Tsu C, Groettrup M.
    J Immunol; 2012 Aug 15; 189(4):1868-77. PubMed ID: 22772448
    [Abstract] [Full Text] [Related]

  • 18. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T, Tatsumi T, Takehara T, Kanto T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    J Gastroenterol Hepatol; 2003 Jan 15; 18(1):32-40. PubMed ID: 12519221
    [Abstract] [Full Text] [Related]

  • 19. Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome.
    Kimoto O, Sawada J, Shimoyama K, Suzuki D, Nakamura S, Hayashi H, Ogawa N.
    J Rheumatol; 2011 Feb 15; 38(2):310-6. PubMed ID: 21078725
    [Abstract] [Full Text] [Related]

  • 20. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
    Zheng L, Yu C, Zhang Z, Yang C, Cai X.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May 15; 107(5):661-8. PubMed ID: 19426920
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.